Renaissance Technologies’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,615,632
| Closed | -$382K | – | 4006 |
|
|
2019
Q4 | $382K | Buy |
2,615,632
+223,844
| +9% | +$32.7K | ﹤0.01% | 2988 |
|
|
2019
Q3 | $359K | Buy |
2,391,788
+436,397
| +22% | +$65.5K | ﹤0.01% | 2981 |
|
|
2019
Q2 | $313K | Buy |
1,955,391
+863,474
| +79% | +$138K | ﹤0.01% | 3162 |
|
|
2019
Q1 | $214K | Buy |
1,091,917
+1,027,040
| +1,583% | +$201K | ﹤0.01% | 3195 |
|
|
2018
Q4 | $45K | Buy |
64,877
+36,107
| +126% | +$25K | ﹤0.01% | 3295 |
|
|
2018
Q3 | $35K | Buy |
28,770
+3,900
| +16% | +$4.75K | ﹤0.01% | 3299 |
|
|
2018
Q2 | $28K | Sell |
24,870
-28,830
| -54% | -$32.5K | ﹤0.01% | 3207 |
|
|
2018
Q1 | $108K | Sell |
53,700
-39,900
| -43% | -$80.2K | ﹤0.01% | 3255 |
|
|
2017
Q4 | $112K | Buy |
93,600
+78,400
| +516% | +$93.8K | ﹤0.01% | 3214 |
|
|
2017
Q3 | $19K | Buy |
+15,200
| New | +$19K | ﹤0.01% | 3157 |
|
|
2015
Q3 | – | Sell |
-43,408
| Closed | -$266K | – | 3468 |
|
|
2015
Q2 | $266K | Buy |
43,408
+18,208
| +72% | +$112K | ﹤0.01% | 2921 |
|
|
2015
Q1 | $203K | Buy |
+25,200
| New | +$203K | ﹤0.01% | 2883 |
|
|
2013
Q3 | – | Sell |
-15,300
| Closed | -$58K | – | 3013 |
|
|
2013
Q2 | $58K | Buy |
+15,300
| New | +$58K | ﹤0.01% | 2683 |
|